Successful treatment of interstitial pneumonia with autoimmune features
using rituximab as salvage therapy
- Abeline Kapuczinski
, - Michel Cotils,
- Yannick Gombeir
Abstract
Interstitial pneumonia with autoimmune features is a concept to identify
patients with idiopathic interstitial pneumonia and features suggestive
of a connective tissue disease. There is no specific treatment which
consists mainly of corticosteroids and immunossupressive agents.
Rituximab is an effective rescue therapy for refractory interstitial
lung disease.19 Feb 2021Submitted to Clinical Case Reports 20 Feb 2021Submission Checks Completed
20 Feb 2021Assigned to Editor
27 Feb 2021Reviewer(s) Assigned
04 Mar 2021Review(s) Completed, Editorial Evaluation Pending
08 Mar 2021Editorial Decision: Revise Minor
02 Apr 20211st Revision Received
03 Apr 2021Submission Checks Completed
03 Apr 2021Assigned to Editor
03 Apr 2021Review(s) Completed, Editorial Evaluation Pending
07 Apr 2021Editorial Decision: Accept
